Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
49 hedge funds and large institutions have $75.1M invested in Rain Oncology Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
20% more funds holding
Funds holding: 41 → 49 (+8)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
62% less capital invested
Capital invested by funds: $195M → $75.1M (-$120M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$4.56M |
| 2 |
BlackRock
New York
|
+$500K |
| 3 |
State Street
Boston,
Massachusetts
|
+$455K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$399K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$227K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$4.76M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.02M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
-$1.77M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$890K |
| 5 |
OWP
Old Well Partners
Charlotte,
North Carolina
|
-$172K |
RAIN Hedge Fund Activity: Q1 2022 in Review
49 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q1 2022, worth a combined $75.1M — down 62% from $195M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new RAIN positions and 2 closed out — a net gain of 8 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was BVF Inc, adding an estimated $4.56M. The largest seller was Janus Henderson Group, cutting an estimated $4.76M.
- 49 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q1 2022, up from 41 in Q4 2021.
- Funds reported $75.1M of Rain Oncology Inc. Common Stock stock for Q1 2022, down 62% quarter-over-quarter.
- 10 funds opened new Rain Oncology Inc. Common Stock positions in Q1 2022 and 2 closed out, a net change of +8 holders.
- The largest Rain Oncology Inc. Common Stock buyer in Q1 2022 was BVF Inc, an estimated $4.56M added.
- The largest Rain Oncology Inc. Common Stock seller in Q1 2022 was Janus Henderson Group, an estimated $4.76M sold.
Based on aggregated 13F filings for Q1 2022.